Literature DB >> 1119939

An attenuated variant of Eastern encephalitis virus: biological properties and protection induced in mice.

A Brown, J E Officer.   

Abstract

Wild type Eastern equine encephalitis virus (E) was compared with a mutant (Em) derived from it. The latter was tested as an attenuated vaccine in mice. They differed in the following properties: Em formed smaller plaques on chick embryo (CE) cell monolayers and, unlike E, did not plaque on mouse embryo (ME) monolayers. Futher, Em had a longer latent period and attained a lower peak titer than E after infection of CE cells, was more senssitive than E to chick interferon, and was less virulent for mice (SC and IP routes) and hamsters (IP route) than E. Both viruses were similar in several other properties tested. The mutant was found to induce a gradient in the specificity of protection in mice against challenge by selected viruses after a single subcutaneous injection of living virus. The protection was best against autologous (Em) challenge, was next best against challenge by the virulent parent (E) virus, but was not demonstrable against cross challenge by Venezuelan encephalitis (V) virus. Conventional hemagglutination-inhibiting (HI), complement-fixing (F), and neutralizing (N) antibodies could not be detected in Em-immunized mice even when fresh monkey or guinea pig serum was included in Ntests to provide complement and/or accessory factor(s). However, N antibodies were detected in protected mice by an indirect antiglobulin test. Passive protection by serum or ascites fluids (a.f.) was characterized by a lower but otherwise similar protection gradient like that found after active immunization with virus as described above. Interferon was not detected in the a.f. used for passive protection, nor was heterologous interference evident in Em immunized mice challenged 18 days later with vaccinia or vesicular stomatitis virus. Immunized mice that survived autologous (Em) challenge showed broadened protection against a second challenge by parent E virus, and cross protection against V virus. This typical protection was associated with the presence of HI and conventional N antibodies, except for V which showed no detectable neutralizing antibodies by either a standard or antiglobulin technique.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1119939     DOI: 10.1007/bf01320552

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  27 in total

1.  RELATIONSHIPS AMONG ARTHROPOD-BORNE ANIMAL VIRUSES DETERMINED BY CROSS-CHALLENGE TESTS.

Authors:  J CASALS
Journal:  Am J Trop Med Hyg       Date:  1963-07       Impact factor: 2.345

2.  DIFFERENCES IN MAXIMUM AND MINIMUM PLAQUE-FORMING TEMPERATURES AMONG SELECTED GROUP A ARBORVIRUSES.

Authors:  A BROWN
Journal:  Virology       Date:  1963-11       Impact factor: 3.616

3.  STUDIES ON JAPANESE B ENCEPHALITIS VIRUS VACCINES FROM TISSUE CULTURE. IV. PREPARATION AND CHARACTERIZATION OF POOL OF ATTENUATED OCT-541 LINE FOR HUMAN VACCINE TRIAL.

Authors:  W M HAMMON; S ROHITAYODHIN; J S RHIM
Journal:  J Immunol       Date:  1963-09       Impact factor: 5.422

4.  Alteration of virulence of Venezuelan equine encephalomyelitis virus after passage in L cell cultures and in mice.

Authors:  H J HEARN; A BROWN; F M HARDY
Journal:  J Infect Dis       Date:  1961 Mar-Apr       Impact factor: 5.226

5.  Cellular immune response to viral infection: in vitro studies of lymphocytes from mice infected with Sindbis virus.

Authors:  D E Griffin; R T Johnson
Journal:  Cell Immunol       Date:  1973-12       Impact factor: 4.868

6.  The pathogenicity of mice of three variants of Mengo encephalomyelitis virus.

Authors:  J S Colter; J B Campbell; L R Hatch
Journal:  J Cell Physiol       Date:  1965-04       Impact factor: 6.384

7.  Defective-interfering particles of Sindbis virus. I. Isolation and some chemical and biological properties.

Authors:  T E Shenk; V Stollar
Journal:  Virology       Date:  1973-05       Impact factor: 3.616

8.  Use of an antiglobulin plaque neutralization test among group A arboviruses.

Authors:  A Brown; V Elsner; E Zebovitz; W P Allen
Journal:  Proc Soc Exp Biol Med       Date:  1969-03

9.  Passive transfer of acquired resistance in mice to group B Arboviruses by serum protective factor(s) (SPF) independent of serum neutralizing antibody or interferon.

Authors:  I S Thind; W H Price
Journal:  Am J Epidemiol       Date:  1968-09       Impact factor: 4.897

10.  Mode of Action of an Inhibitor from Agar on Growth and Hemagglutination of Group A Arboviruses.

Authors:  J I Colón; J B Idoine; O M Brand; R D Costlow
Journal:  J Bacteriol       Date:  1965-07       Impact factor: 3.490

View more
  6 in total

1.  Early events in the pathogenesis of eastern equine encephalitis virus in mice.

Authors:  Peter Vogel; Wayne M Kell; David L Fritz; Michael D Parker; Randal J Schoepp
Journal:  Am J Pathol       Date:  2005-01       Impact factor: 4.307

2.  A vaccine candidate for eastern equine encephalitis virus based on IRES-mediated attenuation.

Authors:  Jyotsna Pandya; Rodion Gorchakov; Eryu Wang; Grace Leal; Scott C Weaver
Journal:  Vaccine       Date:  2012-01-02       Impact factor: 3.641

Review 3.  Alphaviruses: population genetics and determinants of emergence.

Authors:  Scott C Weaver; Richard Winegar; Ian D Manger; Naomi L Forrester
Journal:  Antiviral Res       Date:  2012-04-19       Impact factor: 5.970

4.  Aerosol infection of Balb/c mice with eastern equine encephalitis virus; susceptibility and lethality.

Authors:  Amanda L Phelps; Lyn M O'Brien; Lin S Eastaugh; Carwyn Davies; Mark S Lever; Jane Ennis; Larry Zeitlin; Alejandro Nunez; David O Ulaeto
Journal:  Virol J       Date:  2019-01-05       Impact factor: 4.099

Review 5.  Passive antibody administration (immediate immunity) as a specific defense against biological weapons.

Authors:  Arturo Casadevall
Journal:  Emerg Infect Dis       Date:  2002-08       Impact factor: 6.883

6.  Long-Term Arthralgia after Mayaro Virus Infection Correlates with Sustained Pro-inflammatory Cytokine Response.

Authors:  Felix W Santiago; Eric S Halsey; Crystyan Siles; Stalin Vilcarromero; Carolina Guevara; Jesus A Silvas; Cesar Ramal; Julia S Ampuero; Patricia V Aguilar
Journal:  PLoS Negl Trop Dis       Date:  2015-10-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.